Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

finscreener stocktwits page

Champions Oncology, Inc.

NASDAQ: CSBRHealthcare / Biotechnology / USA
9.99+0.4100+4.28%Vol 67 6321Y Perf 150.13%
Jan 18th, 2019 16:00
BID9.99 ASK10.05
Open9.75 Previous Close9.58
Pre-Market9.50 After-Trading9.99
 -0.08 -0.84%  - -%
Target Price
14.33 
Analyst Rating
Strong Buy 1.00
Potencial %
43.44 
Finscreener Ranking
 —    40.65
Insiders Trans % 3/6/12M
-/-50/33 
Value Ranking
     30.94
Insiders Value % 3/6/12M
37/-58/-54 
Growth Ranking
★★★+     55.85
Insiders Shares Cnt. % 3/6/12M
60/-28/-17 
Income Ranking
 —    -
Market Cap (mil)115 
Earnings Rating
Strong Sell
Price Range Ratio 52wk %
46.73 
Earnings Date
17th Dec 2018

Today's Price Range

9.5910.05

 

52wk Range

3.0517.90

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Month
35.73%
3 Months
-21.77%
6 Months
12.37%
1 Year
150.13%
3 Years
168.55%
5 Years
-30.04%

Quotes

Name / TickerPriceChg.Chg.%
CSBR9.990.41004.28
AAPL156.820.96000.62
GOOG1 098.268.36000.77
MSFT107.711.59001.50
XOM72.990.86001.19
WFC50.010.78001.58
JNJ130.691.60001.24
FB150.041.74001.17
GE9.06-0.0800-0.88
JPM104.591.67001.62
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio
0.90
Current Ratio
0.90
Long Term Debt to Total Capital
0.05
Total Debt to Equity
0.12
Interest Coverage
-
Leverage Ratio 11.00
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin
48.60
EBIT Margin
0.40
EBITDA Margin
2.60
Pre-tax Profit Margin
-71.00
Profit Margin
0.18
ValuationValueIndustryS&P 500US Markets
PE Ratio
-
PB Ratio
54.54
PS Ratios
4.74
Price to Cash Flow
136.60
Price to Free Cash Flow
1 341.30
Cash Flow Per Share
0.07
Price to Tangible Book
82.12
Book Value per Share
0.17
Enterprise Value (in ths.)
106 923
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)
-539.20
ROE last 12 Months
3.55
Return on Assets (5Y Avg)
-94.00
ROA last 12 Months
0.50
Return on Capital (5Y Avg)
-686.98
ROC last 12 Months
2.96
Return on invested Capital Q
17.14
Return on invested Capital Y
-732.51
Assets Turnover
1.20
Receivables Turnover
3.20
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)
22 922
Revenue per Share
2.01
Revenue Growth 3 Years
25.03
Revenue Growth 5 Years
16.51
DividendsValueIndustryS&P 500US Markets
Dividend Yield
-
Dividend Rate
-
Dividend Growth 3 Years
-
Dividend Growth 5 Years
-

Earnings HistoryEstimateReportedSurprise %
Q02 20190.030.02-33.33
Q01 20190.000.04-
Q04 2018-0.04-0.06-50.00
Q04 2016--0.30-
Q03 2016--0.28-
Q02 2016--0.29-
Q01 2016--0.33-
Q04 2015--0.05-
Earnings Per EndEstimateRevision %Trend
1/2019 QR0.03-25.00Negative
4/2019 QR0.03-25.00Negative
4/2019 FY0.12-29.41Negative
4/2020 FY0.250.00-
Next Report Date-
Estimated EPS Next Report0.04
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume67 632
Shares Outstanding (in ths.)11 475
Trades Count333
Dollar Volume621 340
Avg. Volume75 802
Avg. Weekly Volume67 026
Avg. Monthly Volume86 751
Avg. Quarterly Volume104 496

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

32%68%

Bearish Bullish

44%56%

Bearish Bullish

50%50%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (100.00 %)
3 (100.00 %)
3 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News